BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1967337)

  • 1. Metolazone in treatment of severe refractory congestive cardiac failure.
    Kiyingi A; Field MJ; Pawsey CC; Yiannikas J; Lawrence JR; Arter WJ
    Lancet; 1990 Jan; 335(8680):29-31. PubMed ID: 1967337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of furosemide and metolazone in the treatment of severe congestive heart failure.
    Grosskopf I; Rabinovitz M; Rosenfeld JB
    Isr J Med Sci; 1986 Nov; 22(11):787-90. PubMed ID: 3793436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination diuretic treatment in severe heart failure: a randomised controlled trial.
    Channer KS; McLean KA; Lawson-Matthew P; Richardson M
    Br Heart J; 1994 Feb; 71(2):146-50. PubMed ID: 8130022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metolazone in the treatment of refractory heart insufficiency. Experience of 10 cases].
    Kirancumar ; Loureiro PA; Correia JM
    Rev Port Cardiol; 1989 Nov; 8(11):775-8. PubMed ID: 2631826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature.
    Rosenberg J; Gustafsson F; Galatius S; Hildebrandt PR
    Cardiovasc Drugs Ther; 2005 Aug; 19(4):301-6. PubMed ID: 16189620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the sodium excreting efficacy of furosemide and indapamide combination against furosemide and metolazone combination in congestive heart failure patients: A randomized control trial.
    Salahudin M; Shah H; Jan MU; Altaf A
    J Pak Med Assoc; 2019 Dec; 69(12):1794-1799. PubMed ID: 31853105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metolazone in the treatment of advanced therapy-resistant dilated cardiomyopathy].
    Kröger N; Szuba J; Frenzel H
    Med Klin (Munich); 1991 Jun; 86(6):305-8, 332. PubMed ID: 1886511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Intravenous Chlorothiazide versus Oral Metolazone in Patients with Acute Decompensated Heart Failure and Loop Diuretic Resistance.
    Shulenberger CE; Jiang A; Devabhakthuni S; Ivaturi V; Liu T; Reed BN
    Pharmacotherapy; 2016 Aug; 36(8):852-60. PubMed ID: 27393709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metolazone and spironolactone in cirrhosis and the nephrotic syndrome.
    Lang GR; Westenfelder C; Nascimento L; Dhupelia VB; Arruda JA; Kane RE
    Clin Pharmacol Ther; 1977 Feb; 21(2):234-43. PubMed ID: 319937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Intravenous Chlorothiazide for Refractory Acute Decompensated Heart Failure Unresponsive to Adjunct Metolazone.
    Cardinale M; Altshuler J; Testani JM
    Pharmacotherapy; 2016 Aug; 36(8):843-51. PubMed ID: 27321568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term diuretic therapy with metolazone of renal failure and the nephrotic syndrome.
    Paton RR; Kane RE
    J Clin Pharmacol; 1977 Apr; 17(4):243-51. PubMed ID: 849998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metolazone for severe dilated cardiomyopathy refractory to conventional therapy.
    Kröger N; Szuba J; Buhl C; Pompecki R; Frenzel H
    Lancet; 1990 Apr; 335(8696):1031-2. PubMed ID: 1970077
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe electrolyte disturbances associated with metolazone and furosemide.
    Black WD; Shiner PT; Roman J
    South Med J; 1978 Apr; 71(4):380-1, 385. PubMed ID: 635611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial.
    Cox ZL; Hung R; Lenihan DJ; Testani JM
    JACC Heart Fail; 2020 Mar; 8(3):157-168. PubMed ID: 31838029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of metolazone versus chlorothiazide in acute decompensated heart failure with diuretic resistance.
    Moranville MP; Choi S; Hogg J; Anderson AS; Rich JD
    Cardiovasc Ther; 2015 Apr; 33(2):42-9. PubMed ID: 25712736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of premenstrual tension with metolazone: a double-blind evaluation of a new diuretic.
    Werch A; Kane RE
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):565-72. PubMed ID: 819215
    [No Abstract]   [Full Text] [Related]  

  • 17. Antihypertensive efficacy of metolazone (Zaroxolyn) alone and combined with reserpine in treatment of essential hypertension.
    Van Hoose MC; Cutler RE
    Curr Ther Res Clin Exp; 1976 Sep; 20(3):266-76. PubMed ID: 822985
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure.
    Ng TM; Konopka E; Hyderi AF; Hshieh S; Tsuji Y; Kim BJ; Han SY; Phan DH; Jeng AI; Lou M; Elkayam U
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):345-53. PubMed ID: 23538300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metolazone and its role in edema management.
    Sica DA
    Congest Heart Fail; 2003; 9(2):100-5. PubMed ID: 12671341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and clinical effects of metolazone in congestive heart failure.
    Levey BA; Palmer RF
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):641-51. PubMed ID: 812641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.